Skip to Content
Merck
  • Synthesis and pharmacological evaluation of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives as anti-inflammatory and analgesic agents.

Synthesis and pharmacological evaluation of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives as anti-inflammatory and analgesic agents.

European journal of medicinal chemistry (2010-02-23)
Monika Gaba, Dhandeep Singh, Sarbjot Singh, Vikas Sharma, Punam Gaba
ABSTRACT

A series of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives have been synthesized. The structures of these compounds were established by IR, 1H NMR, 13C NMR, Mass spectral data and elemental analyses. Compounds were evaluated for their anti-inflammatory and analgesic activity as well as gastric ulcerogenic effects. Derivatives 4a, 4b and 4c exhibited moderate to good anti-inflammatory and analgesic activity in carrageenan-induced rat paw edema and acetic acid-induced writhing in mice, respectively, with low ulcerogenicity compared with the standard drug indomethacin.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Aspirin, meets USP testing specifications
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
Acetylsalicylic acid, ≥99.0%
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
Acetylsalicylic acid, analytical standard